• Tue, June 18, 2019
  • Wed, June 19, 2019
  • Mon, June 24, 2019
  • Thu, June 20, 2019
  • Fri, June 21, 2019

Jason McCarthy Upgraded (BLUE) to Strong Buy and Held Target at $160 on, Jun 18th, 2019

Jason McCarthy of Maxim Group, Upgraded "bluebird bio, Inc." (BLUE) to Strong Buy and Held Target at $160 on, Jun 18th, 2019.

Jason has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Schmidt of "Leerink Swann" Downgraded from Buy to Hold on, Tuesday, March 5th, 2019


These are the ratings of the 2 analyists that currently disagree with Jason


  • Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $163 on, Monday, June 17th, 2019
  • Yaron Werber of "Cowen & Co." Initiated at Buy on, Tuesday, February 26th, 2019

Like: 👍